Stay updated with breaking news from Accustem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LONDON and PHOENIX, March 01, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTC PINK: ACMSY), a life sciences company dedicated to improving outcomes for patients with cancer, today announced publication
SCHEME OF ARRANGEMENT EFFECTIVE LONDON, Dec. 01, 2021 (GLOBE NEWSWIRE) -- ACCUSTEM UK is pleased to announce that, further to the announcement dated 30 November 2021 that the Court has sanctioned the
(0) NEW YORK and LONDON, April 13, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ:TLSA; LSE: TILS), today announced that its former subsidiary, Accustem Sciences Limited ("Accustem"), intends to file a listing application with the Nasdaq Stock Market shortly after completion of the distribution of shares in Accustem to Tiziana Life Sciences plc shareholders. The board of directors of Accustem has resolved that the Nasdaq listing venue is more appropriate to the nature of Accustem's business. About Accustem Sciences StemPrintER is a multi-gene prognostic assay intended to predict t...